Try a single issue or save on a subscription Issues delivered straight to your door or device ...

Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive ...

Sulthiame (STM) is beneficial for improving symptoms of obstructive sleep apnea (OSA), according to a study presented at the European Respiratory Society Congre ...

A new dose-finding study supported the potential of the carbonic anhydrase inhibitor as an alternative to CPAP machines.

Doctors told Jim Allot he has second worst case of sleep apnoea they'd ever seen. The parasomnia can lead to stroke and heart ...

Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnoea (OSA), according to results of a clinical trial presented at ...

WASHINGTON (dpa-AFX) - A recent study presented at the European Respiratory Society Congress has suggested that the epilepsy medication sulthiame, known by the brand name Ospolot, may offer relief ...

FRIDAY, Sept. 13, 2024 (HealthDay News) -- Sulthiame (STM) is beneficial for improving symptoms of obstructive sleep apnea (OSA), according to a study presented at the European Respiratory Society ...

Patients who took sulthiame had few pauses in their breathing while asleep, as well as higher levels of blood oxygen, according to clinical trial results presented Tuesday at the European ...

An epilepsy drug could help people millions of people in the UK who snore y at night. Sulthiame, a drug sold under the brand name Ospolot, appeared to reduce symptoms of obstructive sleep apnoea in a ...

One drug could become the first effective treatment for millions of snorers – and their long-suffering partners ...